AzTrials
AzTrials

NeuroinflammationNCT03058328

The White Blood Cell Reactivity Following Surgical Trauma and Associated Regulatory Mechanisms.

An observational study of Neuroinflammation, run by Karolinska University Hospital at 1 site in Sweden.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to describe numerical and functional changes in the white blood cell efter surgical trauma. Further, observed immune cell changes correlate to heart rate variability and cognitive function will be assessed. Read more about this study

Who is it for?
Ages 40 to 75 years, men only
Conditions the study is for
Neuroinflammation
What is being tested?
Cognitive testing, testing of heart rate variability and blood samples
How many people
40 participants
Where
1 siteSweden
Study dates
31 Jan 2017to 31 Dec 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 to 75 years
  • Men only
  • No healthy volunteers
  • Adult, Older adult

Study population: Patients with diagnosed prostate disease who are scheduled for elective robot assisted prostate surgery (RALP) and who are otherwise healthy, with a BMI below 33 and who score >23 performance points on Mini-mental state examination (MMSE).

Who may be able to join

  • Diagnosed prostate disease who are scheduled for elective robot assisted prostate surgery (RALP) and who are otherwise healthy
  • A body mass index (BMI) below 33
  • Mini-mental state examination (MMSE) scoring >23

Who cannot join

  • Neurodegenerative disease
  • Significant psychiatric illness
  • Previous stroke
  • Pacemaker, myocardial infarction or cardiac arrhythmias,
  • Known obstructive coronary artery disease, left ventricular hypertrophy or New York Heart Association (NYHA) class 2-4 heart failure
  • Chronic pain or inflammatory disease such as rheumatoid arthritis, inflammatory bowel disease, SLE, psoriasis
Show all 17Show fewer
  • Steroidal therapy
  • Statin medication
  • Medication with ß-blockers, anti-cholinergic medication
  • Poorly controlled diabetes mellitus or any other condition known to cause autonomic dysfunction
  • Abuse of alcohol or drugs
  • Previous splenectomy
  • Presumed uncooperativeness or legal incapacity.
  • The patient should not have:
  • undergone surgery the last 6 months
  • been treated for cancer the last 12 months
  • been treated for infectious disease the previous month.

Trial locations and contacts

1 site in 1 country.

Sweden1 site
  • Karolinska Universitetssjukhuset Solna

    Stockholm

Other trials in Sweden

About this study

Official title: Post-surgery Systemic Inflammation and Neuro-immune Interactions

The purpose of this study is to describe numerical and functional changes in the white blood cell efter surgical trauma. Further, observed immune cell changes correlate to heart rate variability and cognitive function will be assessed.

Read the detailed description

Surgical trauma causes release of damage-associated molecular patterns (DAMPs) and other alarmines (e.g. HMGB-1) targeting receptors on local cells of the innate immune system, such as macrophages. This cellular response to trauma is followed by a rapid release of an array of inflammatory mediators (e.g. TNFα, IL-1B, IL-6, IL-8, IL-10) being dependent on intracellular activation of nuclear factor NF-kB. Until recently it was believed that the brain is protected from this cascade of inflammatory mediators primarily due to an intact blood-brain-barrier (BBB). However, there is now a growing body of evidence that long term impairment of brain functions is associated with trauma-induced activation of the brain innate immune system with subsequent impairment of higher cognitive processes and risk for later permanent dementia. Yet, the link between systemic inflammation and cognitive impairment is not fully understood.

Recent studies have mapped periphery-to-brain-signaling after surgical trauma and the impact of major surgical trauma on the human brain by serial PET-imaging. In series of surgical patients, profound and biphasic changes in brain immune activity after surgery has been demonstrated after major abdominal surgery with signs of early depression followed by an increased immune activity at 3 months postoperatively. These biphasic changes in brain immunity seem to be aligned with simultaneous changes in whole blood immune reactivity to LPS suggesting a close link between brain and peripheral immune systems in regulation of acute inflammation and immune responses. Preclinical work in surgical animal models indicates disruption of the BBB with migration of peripheral macrophages into the brain as a pathway of potential importance. Evidence from an orthopedic surgery model in mice of trauma-induced altered hippocampal neuro-immune activity further raises the question whether peripheral markers of neurodegeneration (S100b, neurofilament light NFL, ptau, beta-amyloid) are associated with POCD.

The immune-regulatory role of the brain via the cholinergic anti-inflammatory reflex pathway (mediated by the vagal nerve) has been identified as potential target for immune-modulatory treatment strategies in systemic inflammation. We have moreover demonstrated a distinct release of human carotid body inflammatory mediators at hypoxia and gene expression related to inflammatory mediators, suggesting a potential role of the human carotid body in periphery-to-brain immune-signaling. Modulation of a vagal nerve-derived inflammatory reflex pathway by electrical stimulation has recently been successfully applied in treatment of chronic inflammation among patients with rheumatoid arthritis.

The hypothesis is that vagal nerve activity modulates systemic inflammation in patients after major surgery and that this modulation is associated with cognitive performance in the postoperative period.

With a more comprehensive understanding of immune-to-brain signaling after surgical trauma and how this biphasic inflammatory response pattern is regulated by cellular and neuronal components, the impact of immune modulation on key processes behind surgery-induced brain dysfunction can be explored, and possible neural and humoral targets for relevant anti-inflammatory treatments established.

In abdominal surgery patients we will map inflammatory periphery-to-brain communication by description of the temporal association between brain regulation of peripheral immunity (i.e., temporal changes in vagal nerve activity as measured by serial measurements of heart rate variability), repeated blood reactivity to LPS by serial ex vivo LPS challenge and simultaneous plasma/serum-borne CNS inflammatory and brain injury biomarkers to explore the impact of changes in systemic and brain immune function after surgery on long-term cognitive performance.

Being tested
Cognitive testing, testing of heart rate variability and blood samples
Keywords
Inflammation/physiopathology, Immune System/immunology,, Neuroimmunomodulation/physiology, General Surgery, Heart Rate/physiology*Vagus Nerve/physiology*
Medical subject headings
Neuroinflammatory Diseases, Inflammation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Cognitive testing, testing of heart rate variability and blood samplesOther

    No intervention. Registration of ECG, cognitive testing and blood sampling is performed in the perioperative period and during follow up.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Changes in subsets of Monocytes after surgical trauma

    Changes in subsets of Monocytes after surgical trauma

    Measured: Up to 6 months after surgery

Secondary outcomes (4)
  1. T-cell numbers after surgical trauma.

    T-cell numbers after surgical trauma.

    Measured: Up to 6 months after surgery

  2. B-cell numbers after surgical trauma.

    B-cell numbers after surgical trauma.

    Measured: Up to 6 months after surgery

  3. T-cell functionality changes after surgical trauma.

    T-cell functionality changes after surgical trauma.

    Measured: Up to 6 months after surgery

  4. B-cell functionality changes after surgical trauma.

    B-cell functionality changes after surgical trauma.

    Measured: Up to 6 months after surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Feb 2017
  2. Study start31 Jan 2017
  3. Primary completion31 Dec 2022
  4. Study completion31 Dec 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Prospective
Enrolment
40 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03058328
Sponsor's protocol ID
POSINI2
Status last verified
Jan 2024
First submitted
13 Jan 2017
Last updated
17 Jan 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Neuroinflammation, run by Karolinska University Hospital at 1 site in Sweden.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 17 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 17 Jan 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Changes in subsets of Monocytes after surgical trauma (time frame: Up to 6 months after surgery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Jan 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in